On the role of Ca2+ in the toxicity of alkylating and oxidizing quinone imines in isolated hepatocytes.
The cytotoxicity of acetaminophen (paracetamol) has been shown to be associated with a disruption of intracellular Ca2+ homeostasis caused by the interaction of its metabolite N-acetyl-p-benzoquinone imine (NAPQI) with hepatocyte thiols [Moore, M., et al. (1985) J. Biol. Chem. 260, 13035-13040]. Inasmuch as NAPQI can both covalently bind to thiols and oxidize thiols, we investigated the effects of two dimethylated analogues of NAPQI, one of which (2,6-dimethyl-NAPQI) primarily binds to thiols and the other of which (3,5-dimethyl-NAPQI) primarily oxidizes thiols. Of the three compounds, 2,6-dimethyl-NAPQI decreased protein thiols to the greatest extent and also inhibited hepatocyte plasma membrane Ca(2+)-ATPase to the greatest extent. The 3,5-dimethylated analogue decreased protein thiols to the least extent and inhibited the plasma membrane Ca(2+)-ATPase to a lesser extent. The cytotoxicity of all three compounds was preceded by a sustained elevation in cytosolic Ca2+ as compared to the transient rise caused by the alpha-agonist phenylephrine. Again, the 2,6-dimethyl analogue was the most potent of the three compounds. The thiol reagent dithiothreitol (DTT), which reversed the inhibition of the Ca(2+)-ATPase and the rise in cytosolic Ca2+, also protected against cytotoxicity. Agents that are known to inhibit either Ca(2+)-dependent proteases or phospholipases significantly delayed the onset of cytotoxicity caused by NAPQI and its analogues. Our results suggest that both arylation and oxidation of protein thiols may result in the elevation of cytosolic Ca2+ and in cytotoxicity and that arylation of critical thiol groups appears to be the more lethal reaction.
Nicotera
P
P
Department of Toxicology, Karolinska Institutet, Stockholm, Sweden.
Rundgren
M
M
Porubek
D J
DJ
Cotgreave
I
I
Moldéus
P
P
Orrenius
S
S
Nelson
S D
SD
D000478:Alkylation; D000818:Animals; D016227:Benzoquinones / Q000378:metabolism / Q000633:toxicity*; D002118:Calcium / Q000378:metabolism / Q000502:physiology*; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors; D002462:Cell Membrane / Q000201:enzymology; D003600:Cytosol / Q000378:metabolism; D004963:Estrenes / Q000494:pharmacology; D007097:Imines / Q000378:metabolism / Q000633:toxicity*; D008099:Liver / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D008297:Male; D008745:Methylation; D010084:Oxidation-Reduction; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D010740:Phospholipases / Q000037:antagonists & inhibitors; D011480:Protease Inhibitors / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013438:Sulfhydryl Compounds / Q000378:metabolism
D016227:Benzoquinones; D004963:Estrenes; D007097:Imines; D010726:Phosphodiesterase Inhibitors; D011480:Protease Inhibitors; D011506:Proteins; D013438:Sulfhydryl Compounds; C057358:U 26384; C040069:N-acetyl-3,5-dimethyl-4-benzoquinone imine; C040070:acetyl-2,6-dimethyl-4-benzoquinone imine; D010740:Phospholipases; D000252:Calcium-Transporting ATPases; C028473:N-acetyl-4-benzoquinoneimine; D002118:Calcium